Table 4.
The Relationships of Basal Cytokine Levels with Clinicopathological Features and the Clinical Responses to Chemotherapy among Ovarian/Fallopian Tube Cancer Patients
| Basal IL-6 level | Basal IL-8 level | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Clinicopathological parameters | Low (n=1) | Medium (n=13) | High (n=5) | P value | Low (n=2) | Medium (n=12) | High (n=5) | P value | |
| Age (y) (n=19) | < 60 (n=12) | 0 | 8 | 4 | 0.311 | 2 | 7 | 3 | 0.52 |
| ≥ 60 (n=7) | 1 | 5 | 1 | 0 | 5 | 2 | |||
| FIGO staging (n=19) | Early (n=8) | 0 | 6 | 2 | 0.662 | 0 | 6 | 2 | 0.413 |
| Late (n=11) | 1 | 7 | 3 | 2 | 6 | 3 | |||
| Histological types (n=19) | Serous (n=13) | 1 | 8 | 4 | 0.168 | 2 | 6 | 5 | 0.077 |
| Mucinous (n=2) | 0 | 2 | 0 | 0 | 2 | 0 | |||
| Endometroid(n=3) | 0 | 2 | 1 | 0 | 3 | 0 | |||
| Granulosa (n=1) | 0 | 1 | 0 | 0 | 1 | 0 | |||
| Clinical response (n=10) | Responsive (n=7) | 0 | 6 | 1 | 0.49 | 1 | 4 | 2 | 0.788 |
| Non-responsive (n=3) | 0 | 2 | 1 | 0 | 2 | 1 | |||
| Ex-vivo drug sensitivity | EDR (n=6) | 0 | 5 | 1 | 0.172 | 2 | 3 | 1 | 0.298 |
| (n=19) | IDR (n=3) | 1 | 1 | 1 | 0 | 2 | 1 | ||
| LDR (n=10) | 0 | 7 | 3 | 0 | 7 | 3 | |||
EDR, extreme drug resistance; IDR, intermediate drug resistance; LDR, low drug resistance.